Lv1
2 积分 2024-01-08 加入
[Neoadjuvant immunotherapy for colorectal cancer]
25天前
已完结
Consensus guidance of immune checkpoint inhibitors in locally advanced rectal cancer
25天前
已完结
Interpretable MRI-based Multiparametric Radiomics for Preoperative Prediction of CMS4 Colorectal Cancer
1个月前
已完结
Rechallenge with immune checkpoint inhibitors for advanced esophageal squamous cell carcinoma
3个月前
已完结
Combining gut microbiota modulation and immunotherapy: A promising approach for treating microsatellite stable colorectal cancer
3个月前
已完结
Inhibition of TGF-β in Bone Marrow Endothelial Progenitor Cells Promotes Hematopoietic Recovery in Acute Myeloid Leukemia after Chemotherapy
4个月前
已完结
Efficacy and safety of SHR-1701 combined with chemoradiotherapy as neoadjuvant treatment for locally advanced rectal cancer
4个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
6个月前
已完结
Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study
8个月前
已完结
Magnesium Isoglycyrrhizinate Combined With Steroid Is Superior to Steroid Monotherapy in Checkpoint Inhibitor‐Induced Liver Injury
11个月前
已完结
皖公网安备34019202002308
